nodes	percent_of_prediction	percent_of_DWPC	metapath
Lomitapide—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.133	0.215	CbGbCtD
Lomitapide—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0896	0.145	CbGbCtD
Lomitapide—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0855	0.139	CbGbCtD
Lomitapide—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0762	0.124	CbGbCtD
Lomitapide—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.0746	0.121	CbGbCtD
Lomitapide—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.0705	0.114	CbGbCtD
Lomitapide—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0447	0.0726	CbGbCtD
Lomitapide—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0422	0.0685	CbGbCtD
Lomitapide—CYP3A4—Lidocaine metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00278	0.0774	CbGpPWpGaD
Lomitapide—CYP3A4—Aflatoxin B1 metabolism—EPHX1—chronic obstructive pulmonary disease	0.00246	0.0684	CbGpPWpGaD
Lomitapide—MTTP—Lipoprotein metabolism—ALB—chronic obstructive pulmonary disease	0.00234	0.065	CbGpPWpGaD
Lomitapide—CYP3A4—Benzo(a)pyrene metabolism—EPHX1—chronic obstructive pulmonary disease	0.00201	0.056	CbGpPWpGaD
Lomitapide—MTTP—Lipid and lipoprotein metabolism—ALB—chronic obstructive pulmonary disease	0.00155	0.0432	CbGpPWpGaD
Lomitapide—Feeling abnormal—Roflumilast—chronic obstructive pulmonary disease	0.00126	0.00361	CcSEcCtD
Lomitapide—Angina pectoris—Salbutamol—chronic obstructive pulmonary disease	0.00125	0.0036	CcSEcCtD
Lomitapide—Gastrointestinal pain—Roflumilast—chronic obstructive pulmonary disease	0.00125	0.00358	CcSEcCtD
Lomitapide—Mediastinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.00122	0.00349	CcSEcCtD
Lomitapide—Hepatomegaly—Prednisone—chronic obstructive pulmonary disease	0.00121	0.00346	CcSEcCtD
Lomitapide—Abdominal pain—Roflumilast—chronic obstructive pulmonary disease	0.00121	0.00346	CcSEcCtD
Lomitapide—Infestation NOS—Montelukast—chronic obstructive pulmonary disease	0.00119	0.00341	CcSEcCtD
Lomitapide—Infestation—Montelukast—chronic obstructive pulmonary disease	0.00119	0.00341	CcSEcCtD
Lomitapide—Malnutrition—Tiotropium—chronic obstructive pulmonary disease	0.00117	0.00337	CcSEcCtD
Lomitapide—Haematuria—Formoterol—chronic obstructive pulmonary disease	0.00116	0.00332	CcSEcCtD
Lomitapide—Haematuria—Arformoterol—chronic obstructive pulmonary disease	0.00116	0.00332	CcSEcCtD
Lomitapide—MTTP—Circadian rythm related genes—SLC6A4—chronic obstructive pulmonary disease	0.00114	0.0318	CbGpPWpGaD
Lomitapide—Sinusitis—Formoterol—chronic obstructive pulmonary disease	0.00114	0.00327	CcSEcCtD
Lomitapide—Sinusitis—Arformoterol—chronic obstructive pulmonary disease	0.00114	0.00327	CcSEcCtD
Lomitapide—Back pain—Tiotropium—chronic obstructive pulmonary disease	0.00114	0.00326	CcSEcCtD
Lomitapide—Hepatobiliary disease—Montelukast—chronic obstructive pulmonary disease	0.00112	0.00323	CcSEcCtD
Lomitapide—Sinusitis—Montelukast—chronic obstructive pulmonary disease	0.00112	0.0032	CcSEcCtD
Lomitapide—Palpitations—Aminophylline—chronic obstructive pulmonary disease	0.0011	0.00316	CcSEcCtD
Lomitapide—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.00109	0.00314	CcSEcCtD
Lomitapide—Haematuria—Salbutamol—chronic obstructive pulmonary disease	0.00109	0.00314	CcSEcCtD
Lomitapide—Urinary tract disorder—Arformoterol—chronic obstructive pulmonary disease	0.00108	0.00309	CcSEcCtD
Lomitapide—Urinary tract disorder—Formoterol—chronic obstructive pulmonary disease	0.00108	0.00309	CcSEcCtD
Lomitapide—Sinusitis—Salbutamol—chronic obstructive pulmonary disease	0.00107	0.00309	CcSEcCtD
Lomitapide—Connective tissue disorder—Formoterol—chronic obstructive pulmonary disease	0.00107	0.00307	CcSEcCtD
Lomitapide—Connective tissue disorder—Arformoterol—chronic obstructive pulmonary disease	0.00107	0.00307	CcSEcCtD
Lomitapide—Urethral disorder—Formoterol—chronic obstructive pulmonary disease	0.00107	0.00307	CcSEcCtD
Lomitapide—Urethral disorder—Arformoterol—chronic obstructive pulmonary disease	0.00107	0.00307	CcSEcCtD
Lomitapide—Ecchymosis—Prednisolone—chronic obstructive pulmonary disease	0.00106	0.00305	CcSEcCtD
Lomitapide—Urinary tract disorder—Montelukast—chronic obstructive pulmonary disease	0.00105	0.00303	CcSEcCtD
Lomitapide—Connective tissue disorder—Montelukast—chronic obstructive pulmonary disease	0.00105	0.00301	CcSEcCtD
Lomitapide—MTTP—Circadian rythm related genes—ADIPOQ—chronic obstructive pulmonary disease	0.00105	0.0292	CbGpPWpGaD
Lomitapide—Urethral disorder—Montelukast—chronic obstructive pulmonary disease	0.00105	0.003	CcSEcCtD
Lomitapide—MTTP—Circadian rythm related genes—HDAC2—chronic obstructive pulmonary disease	0.00104	0.0291	CbGpPWpGaD
Lomitapide—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.00104	0.003	CcSEcCtD
Lomitapide—Palpitations—Tiotropium—chronic obstructive pulmonary disease	0.00104	0.00298	CcSEcCtD
Lomitapide—CYP3A4—Aflatoxin B1 metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00102	0.0284	CbGpPWpGaD
Lomitapide—Urinary tract disorder—Salbutamol—chronic obstructive pulmonary disease	0.00102	0.00292	CcSEcCtD
Lomitapide—Cardiac disorder—Formoterol—chronic obstructive pulmonary disease	0.00101	0.0029	CcSEcCtD
Lomitapide—Cardiac disorder—Arformoterol—chronic obstructive pulmonary disease	0.00101	0.0029	CcSEcCtD
Lomitapide—Connective tissue disorder—Salbutamol—chronic obstructive pulmonary disease	0.00101	0.0029	CcSEcCtD
Lomitapide—Infection—Aminophylline—chronic obstructive pulmonary disease	0.00101	0.0029	CcSEcCtD
Lomitapide—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.00101	0.0029	CcSEcCtD
Lomitapide—Urethral disorder—Salbutamol—chronic obstructive pulmonary disease	0.00101	0.0029	CcSEcCtD
Lomitapide—Myalgia—Tiotropium—chronic obstructive pulmonary disease	0.001	0.00287	CcSEcCtD
Lomitapide—Arthralgia—Tiotropium—chronic obstructive pulmonary disease	0.001	0.00287	CcSEcCtD
Lomitapide—Chest pain—Tiotropium—chronic obstructive pulmonary disease	0.001	0.00287	CcSEcCtD
Lomitapide—Nervous system disorder—Aminophylline—chronic obstructive pulmonary disease	0.000997	0.00286	CcSEcCtD
Lomitapide—Unspecified disorder of skin and subcutaneous tissue—Tiotropium—chronic obstructive pulmonary disease	0.000993	0.00285	CcSEcCtD
Lomitapide—Cardiac disorder—Montelukast—chronic obstructive pulmonary disease	0.00099	0.00284	CcSEcCtD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000989	0.0275	CbGpPWpGaD
Lomitapide—Mediastinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000982	0.00282	CcSEcCtD
Lomitapide—Mediastinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000982	0.00282	CcSEcCtD
Lomitapide—Dry mouth—Tiotropium—chronic obstructive pulmonary disease	0.000978	0.00281	CcSEcCtD
Lomitapide—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.000969	0.00278	CcSEcCtD
Lomitapide—Mediastinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000962	0.00276	CcSEcCtD
Lomitapide—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000955	0.00274	CcSEcCtD
Lomitapide—Cardiac disorder—Salbutamol—chronic obstructive pulmonary disease	0.000955	0.00274	CcSEcCtD
Lomitapide—Infection—Tiotropium—chronic obstructive pulmonary disease	0.000953	0.00274	CcSEcCtD
Lomitapide—Malnutrition—Formoterol—chronic obstructive pulmonary disease	0.000948	0.00272	CcSEcCtD
Lomitapide—Malnutrition—Arformoterol—chronic obstructive pulmonary disease	0.000948	0.00272	CcSEcCtD
Lomitapide—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.00094	0.0027	CcSEcCtD
Lomitapide—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.000931	0.00268	CcSEcCtD
Lomitapide—Mediastinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000927	0.00266	CcSEcCtD
Lomitapide—Chills—Salbutamol—chronic obstructive pulmonary disease	0.000923	0.00265	CcSEcCtD
Lomitapide—Back pain—Formoterol—chronic obstructive pulmonary disease	0.000917	0.00263	CcSEcCtD
Lomitapide—Back pain—Arformoterol—chronic obstructive pulmonary disease	0.000917	0.00263	CcSEcCtD
Lomitapide—Muscle spasms—Arformoterol—chronic obstructive pulmonary disease	0.000912	0.00262	CcSEcCtD
Lomitapide—Muscle spasms—Formoterol—chronic obstructive pulmonary disease	0.000912	0.00262	CcSEcCtD
Lomitapide—Increased appetite—Prednisolone—chronic obstructive pulmonary disease	0.000908	0.00261	CcSEcCtD
Lomitapide—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000906	0.0026	CcSEcCtD
Lomitapide—Malnutrition—Salbutamol—chronic obstructive pulmonary disease	0.000895	0.00257	CcSEcCtD
Lomitapide—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.000895	0.00257	CcSEcCtD
Lomitapide—Muscle spasms—Montelukast—chronic obstructive pulmonary disease	0.000893	0.00256	CcSEcCtD
Lomitapide—Dermatitis bullous—Prednisolone—chronic obstructive pulmonary disease	0.000892	0.00256	CcSEcCtD
Lomitapide—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.000884	0.00254	CcSEcCtD
Lomitapide—Flatulence—Salbutamol—chronic obstructive pulmonary disease	0.000882	0.00253	CcSEcCtD
Lomitapide—Ill-defined disorder—Arformoterol—chronic obstructive pulmonary disease	0.00088	0.00253	CcSEcCtD
Lomitapide—Ill-defined disorder—Formoterol—chronic obstructive pulmonary disease	0.00088	0.00253	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.000874	0.00251	CcSEcCtD
Lomitapide—Back pain—Salbutamol—chronic obstructive pulmonary disease	0.000866	0.00249	CcSEcCtD
Lomitapide—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.000861	0.00247	CcSEcCtD
Lomitapide—Muscle spasms—Salbutamol—chronic obstructive pulmonary disease	0.000861	0.00247	CcSEcCtD
Lomitapide—Malaise—Formoterol—chronic obstructive pulmonary disease	0.000855	0.00246	CcSEcCtD
Lomitapide—Malaise—Arformoterol—chronic obstructive pulmonary disease	0.000855	0.00246	CcSEcCtD
Lomitapide—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.000844	0.00242	CcSEcCtD
Lomitapide—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.000838	0.00241	CcSEcCtD
Lomitapide—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.000838	0.00241	CcSEcCtD
Lomitapide—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000831	0.00239	CcSEcCtD
Lomitapide—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	0.000831	0.00239	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000828	0.00238	CcSEcCtD
Lomitapide—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.000821	0.00236	CcSEcCtD
Lomitapide—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.00082	0.00236	CcSEcCtD
Lomitapide—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.000807	0.00232	CcSEcCtD
Lomitapide—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.000807	0.00232	CcSEcCtD
Lomitapide—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.000807	0.00232	CcSEcCtD
Lomitapide—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.000807	0.00232	CcSEcCtD
Lomitapide—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.000807	0.00232	CcSEcCtD
Lomitapide—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.000807	0.00232	CcSEcCtD
Lomitapide—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.000807	0.00232	CcSEcCtD
Lomitapide—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.000804	0.00231	CcSEcCtD
Lomitapide—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000804	0.00231	CcSEcCtD
Lomitapide—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000804	0.00231	CcSEcCtD
Lomitapide—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000802	0.0023	CcSEcCtD
Lomitapide—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000802	0.0023	CcSEcCtD
Lomitapide—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.000798	0.00229	CcSEcCtD
Lomitapide—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000798	0.00229	CcSEcCtD
Lomitapide—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000791	0.00227	CcSEcCtD
Lomitapide—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.000791	0.00227	CcSEcCtD
Lomitapide—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.000791	0.00227	CcSEcCtD
Lomitapide—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.00079	0.00227	CcSEcCtD
Lomitapide—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.00079	0.00227	CcSEcCtD
Lomitapide—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000785	0.00226	CcSEcCtD
Lomitapide—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000784	0.00225	CcSEcCtD
Lomitapide—CYP3A4—Aflatoxin B1 metabolism—GSTM1—chronic obstructive pulmonary disease	0.000783	0.0218	CbGpPWpGaD
Lomitapide—Dry skin—Prednisolone—chronic obstructive pulmonary disease	0.000782	0.00224	CcSEcCtD
Lomitapide—Ecchymosis—Prednisone—chronic obstructive pulmonary disease	0.000772	0.00222	CcSEcCtD
Lomitapide—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000769	0.00221	CcSEcCtD
Lomitapide—Infection—Formoterol—chronic obstructive pulmonary disease	0.000769	0.00221	CcSEcCtD
Lomitapide—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000762	0.00219	CcSEcCtD
Lomitapide—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000762	0.00219	CcSEcCtD
Lomitapide—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000762	0.00219	CcSEcCtD
Lomitapide—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000759	0.00218	CcSEcCtD
Lomitapide—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000759	0.00218	CcSEcCtD
Lomitapide—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000758	0.00218	CcSEcCtD
Lomitapide—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000753	0.00216	CcSEcCtD
Lomitapide—Infection—Montelukast—chronic obstructive pulmonary disease	0.000753	0.00216	CcSEcCtD
Lomitapide—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000752	0.00216	CcSEcCtD
Lomitapide—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000752	0.00216	CcSEcCtD
Lomitapide—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000745	0.00214	CcSEcCtD
Lomitapide—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000743	0.00214	CcSEcCtD
Lomitapide—Abdominal distension—Prednisolone—chronic obstructive pulmonary disease	0.000742	0.00213	CcSEcCtD
Lomitapide—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000736	0.00211	CcSEcCtD
Lomitapide—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000726	0.00209	CcSEcCtD
Lomitapide—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000717	0.00206	CcSEcCtD
Lomitapide—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.00071	0.00204	CcSEcCtD
Lomitapide—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000706	0.00203	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000705	0.00203	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000705	0.00203	CcSEcCtD
Lomitapide—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000696	0.002	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000691	0.00198	CcSEcCtD
Lomitapide—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000688	0.00198	CcSEcCtD
Lomitapide—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000688	0.00198	CcSEcCtD
Lomitapide—MTTP—Metabolism—APIP—chronic obstructive pulmonary disease	0.000684	0.019	CbGpPWpGaD
Lomitapide—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000681	0.00196	CcSEcCtD
Lomitapide—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000681	0.00196	CcSEcCtD
Lomitapide—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000681	0.00195	CcSEcCtD
Lomitapide—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000674	0.00194	CcSEcCtD
Lomitapide—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000672	0.00193	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000668	0.00192	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000668	0.00192	CcSEcCtD
Lomitapide—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000667	0.00192	CcSEcCtD
Lomitapide—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000667	0.00192	CcSEcCtD
Lomitapide—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000667	0.00192	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000666	0.00191	CcSEcCtD
Lomitapide—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000662	0.0019	CcSEcCtD
Lomitapide—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000662	0.0019	CcSEcCtD
Lomitapide—Increased appetite—Prednisone—chronic obstructive pulmonary disease	0.00066	0.00189	CcSEcCtD
Lomitapide—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000656	0.00188	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000654	0.00188	CcSEcCtD
Lomitapide—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000654	0.00188	CcSEcCtD
Lomitapide—MTTP—Circadian rythm related genes—LEP—chronic obstructive pulmonary disease	0.000651	0.0181	CbGpPWpGaD
Lomitapide—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.00065	0.00187	CcSEcCtD
Lomitapide—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000647	0.00186	CcSEcCtD
Lomitapide—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000643	0.00185	CcSEcCtD
Lomitapide—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000638	0.00183	CcSEcCtD
Lomitapide—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000638	0.00183	CcSEcCtD
Lomitapide—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000637	0.00183	CcSEcCtD
Lomitapide—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000635	0.00182	CcSEcCtD
Lomitapide—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000634	0.00182	CcSEcCtD
Lomitapide—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000633	0.00182	CcSEcCtD
Lomitapide—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000633	0.00182	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000631	0.00181	CcSEcCtD
Lomitapide—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.00063	0.00181	CcSEcCtD
Lomitapide—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000625	0.00179	CcSEcCtD
Lomitapide—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.00062	0.00178	CcSEcCtD
Lomitapide—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000612	0.00176	CcSEcCtD
Lomitapide—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000612	0.00176	CcSEcCtD
Lomitapide—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000612	0.00176	CcSEcCtD
Lomitapide—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000612	0.00176	CcSEcCtD
Lomitapide—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.00061	0.00175	CcSEcCtD
Lomitapide—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000607	0.0169	CbGpPWpGaD
Lomitapide—MTTP—Circadian rythm related genes—NOS2—chronic obstructive pulmonary disease	0.000607	0.0169	CbGpPWpGaD
Lomitapide—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000604	0.00173	CcSEcCtD
Lomitapide—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000602	0.00173	CcSEcCtD
Lomitapide—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000601	0.00173	CcSEcCtD
Lomitapide—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000599	0.00172	CcSEcCtD
Lomitapide—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000599	0.00172	CcSEcCtD
Lomitapide—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000598	0.00172	CcSEcCtD
Lomitapide—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000578	0.00166	CcSEcCtD
Lomitapide—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000578	0.00166	CcSEcCtD
Lomitapide—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.00057	0.00164	CcSEcCtD
Lomitapide—Dry skin—Prednisone—chronic obstructive pulmonary disease	0.000568	0.00163	CcSEcCtD
Lomitapide—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000555	0.00159	CcSEcCtD
Lomitapide—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000555	0.00159	CcSEcCtD
Lomitapide—Alanine aminotransferase increased—Prednisone—chronic obstructive pulmonary disease	0.000547	0.00157	CcSEcCtD
Lomitapide—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000544	0.00156	CcSEcCtD
Lomitapide—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	0.000539	0.00155	CcSEcCtD
Lomitapide—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000529	0.00152	CcSEcCtD
Lomitapide—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000529	0.00152	CcSEcCtD
Lomitapide—CYP3A4—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.000527	0.0147	CbGpPWpGaD
Lomitapide—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000524	0.00151	CcSEcCtD
Lomitapide—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000519	0.00149	CcSEcCtD
Lomitapide—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000512	0.00147	CcSEcCtD
Lomitapide—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000512	0.00147	CcSEcCtD
Lomitapide—MTTP—Circadian rythm related genes—SERPINE1—chronic obstructive pulmonary disease	0.000511	0.0142	CbGpPWpGaD
Lomitapide—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000501	0.00144	CcSEcCtD
Lomitapide—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.0005	0.00144	CcSEcCtD
Lomitapide—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000492	0.00141	CcSEcCtD
Lomitapide—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000492	0.00141	CcSEcCtD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	0.000487	0.0136	CbGpPWpGaD
Lomitapide—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000485	0.00139	CcSEcCtD
Lomitapide—Headache—Formoterol—chronic obstructive pulmonary disease	0.000485	0.00139	CcSEcCtD
Lomitapide—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.000485	0.00139	CcSEcCtD
Lomitapide—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000483	0.00139	CcSEcCtD
Lomitapide—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000482	0.00138	CcSEcCtD
Lomitapide—CYP3A4—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00048	0.0134	CbGpPWpGaD
Lomitapide—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000476	0.00137	CcSEcCtD
Lomitapide—Headache—Montelukast—chronic obstructive pulmonary disease	0.000475	0.00136	CcSEcCtD
Lomitapide—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000468	0.013	CbGpPWpGaD
Lomitapide—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000465	0.00133	CcSEcCtD
Lomitapide—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000463	0.00133	CcSEcCtD
Lomitapide—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000461	0.00133	CcSEcCtD
Lomitapide—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.00046	0.00132	CcSEcCtD
Lomitapide—Nausea—Formoterol—chronic obstructive pulmonary disease	0.00046	0.00132	CcSEcCtD
Lomitapide—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	0.000459	0.0128	CbGpPWpGaD
Lomitapide—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000458	0.00131	CcSEcCtD
Lomitapide—MTTP—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000453	0.0126	CbGpPWpGaD
Lomitapide—Nausea—Montelukast—chronic obstructive pulmonary disease	0.00045	0.00129	CcSEcCtD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	0.000449	0.0125	CbGpPWpGaD
Lomitapide—CYP3A4—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000441	0.0123	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—GC—chronic obstructive pulmonary disease	0.000441	0.0123	CbGpPWpGaD
Lomitapide—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000434	0.00125	CcSEcCtD
Lomitapide—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000432	0.00124	CcSEcCtD
Lomitapide—CYP3A4—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000424	0.0118	CbGpPWpGaD
Lomitapide—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000421	0.00121	CcSEcCtD
Lomitapide—MTTP—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.00041	0.0114	CbGpPWpGaD
Lomitapide—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000405	0.00116	CcSEcCtD
Lomitapide—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000401	0.00115	CcSEcCtD
Lomitapide—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000383	0.0107	CbGpPWpGaD
Lomitapide—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000376	0.00108	CcSEcCtD
Lomitapide—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000373	0.00107	CcSEcCtD
Lomitapide—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000368	0.0102	CbGpPWpGaD
Lomitapide—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000349	0.0097	CbGpPWpGaD
Lomitapide—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000346	0.000994	CcSEcCtD
Lomitapide—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000345	0.000992	CcSEcCtD
Lomitapide—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000345	0.000991	CcSEcCtD
Lomitapide—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000337	0.000967	CcSEcCtD
Lomitapide—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000335	0.000963	CcSEcCtD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	0.000326	0.00908	CbGpPWpGaD
Lomitapide—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.00032	0.00892	CbGpPWpGaD
Lomitapide—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000318	0.000912	CcSEcCtD
Lomitapide—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000318	0.000912	CcSEcCtD
Lomitapide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000316	0.000906	CcSEcCtD
Lomitapide—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000314	0.000902	CcSEcCtD
Lomitapide—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000308	0.00857	CbGpPWpGaD
Lomitapide—Infection—Prednisone—chronic obstructive pulmonary disease	0.000303	0.000869	CcSEcCtD
Lomitapide—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000299	0.000858	CcSEcCtD
Lomitapide—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000296	0.00085	CcSEcCtD
Lomitapide—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000294	0.000846	CcSEcCtD
Lomitapide—ABCB1—Allograft Rejection—IL13—chronic obstructive pulmonary disease	0.000292	0.00813	CbGpPWpGaD
Lomitapide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000288	0.00803	CbGpPWpGaD
Lomitapide—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000277	0.000797	CcSEcCtD
Lomitapide—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000277	0.000796	CcSEcCtD
Lomitapide—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000273	0.000785	CcSEcCtD
Lomitapide—ABCB1—Allograft Rejection—IL17A—chronic obstructive pulmonary disease	0.000269	0.00748	CbGpPWpGaD
Lomitapide—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000268	0.00077	CcSEcCtD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—RAPGEF3—chronic obstructive pulmonary disease	0.000266	0.00742	CbGpPWpGaD
Lomitapide—MTTP—Circadian rythm related genes—TP53—chronic obstructive pulmonary disease	0.000266	0.00739	CbGpPWpGaD
Lomitapide—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000265	0.00076	CcSEcCtD
Lomitapide—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000263	0.000754	CcSEcCtD
Lomitapide—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000263	0.000754	CcSEcCtD
Lomitapide—Constipation—Prednisone—chronic obstructive pulmonary disease	0.00026	0.000748	CcSEcCtD
Lomitapide—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000251	0.000721	CcSEcCtD
Lomitapide—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000249	0.000715	CcSEcCtD
Lomitapide—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000249	0.000715	CcSEcCtD
Lomitapide—MTTP—Circadian rythm related genes—IL6—chronic obstructive pulmonary disease	0.000243	0.00676	CbGpPWpGaD
Lomitapide—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000241	0.000691	CcSEcCtD
Lomitapide—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000241	0.000691	CcSEcCtD
Lomitapide—MTTP—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000241	0.0067	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000238	0.00662	CbGpPWpGaD
Lomitapide—ABCB1—HIF-1-alpha transcription factor network—HMOX1—chronic obstructive pulmonary disease	0.000226	0.0063	CbGpPWpGaD
Lomitapide—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000226	0.0063	CbGpPWpGaD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	0.000222	0.00617	CbGpPWpGaD
Lomitapide—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000219	0.000628	CcSEcCtD
Lomitapide—MTTP—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000217	0.00604	CbGpPWpGaD
Lomitapide—ABCB1—HIF-1-alpha transcription factor network—EDN1—chronic obstructive pulmonary disease	0.000213	0.00594	CbGpPWpGaD
Lomitapide—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000208	0.000599	CcSEcCtD
Lomitapide—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000201	0.000578	CcSEcCtD
Lomitapide—MTTP—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.0002	0.00557	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000196	0.00545	CbGpPWpGaD
Lomitapide—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000194	0.000556	CcSEcCtD
Lomitapide—Headache—Prednisone—chronic obstructive pulmonary disease	0.000191	0.000548	CcSEcCtD
Lomitapide—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000187	0.00521	CbGpPWpGaD
Lomitapide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000183	0.0051	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—IL10—chronic obstructive pulmonary disease	0.000183	0.00509	CbGpPWpGaD
Lomitapide—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000181	0.00052	CcSEcCtD
Lomitapide—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000181	0.00503	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000175	0.00486	CbGpPWpGaD
Lomitapide—ABCB1—HIF-1-alpha transcription factor network—LEP—chronic obstructive pulmonary disease	0.000174	0.00483	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000167	0.00464	CbGpPWpGaD
Lomitapide—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000165	0.00458	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000165	0.00458	CbGpPWpGaD
Lomitapide—ABCB1—HIF-1-alpha transcription factor network—NOS2—chronic obstructive pulmonary disease	0.000162	0.0045	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000153	0.00427	CbGpPWpGaD
Lomitapide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000148	0.00413	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000145	0.00404	CbGpPWpGaD
Lomitapide—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—chronic obstructive pulmonary disease	0.000136	0.00379	CbGpPWpGaD
Lomitapide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000133	0.0037	CbGpPWpGaD
Lomitapide—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000131	0.00365	CbGpPWpGaD
Lomitapide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000108	0.003	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—CXCL8—chronic obstructive pulmonary disease	9.99e-05	0.00278	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—ALB—chronic obstructive pulmonary disease	9.88e-05	0.00275	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—IL1B—chronic obstructive pulmonary disease	9.59e-05	0.00267	CbGpPWpGaD
Lomitapide—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	9.49e-05	0.00264	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—NOS3—chronic obstructive pulmonary disease	9.45e-05	0.00263	CbGpPWpGaD
Lomitapide—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	9.38e-05	0.00261	CbGpPWpGaD
Lomitapide—ABCB1—HIF-1-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	9.37e-05	0.00261	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—VEGFA—chronic obstructive pulmonary disease	8.12e-05	0.00226	CbGpPWpGaD
Lomitapide—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	7.88e-05	0.00219	CbGpPWpGaD
Lomitapide—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	7.78e-05	0.00216	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—APIP—chronic obstructive pulmonary disease	7.48e-05	0.00208	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—TGFB1—chronic obstructive pulmonary disease	7.45e-05	0.00207	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—TNF—chronic obstructive pulmonary disease	6.96e-05	0.00194	CbGpPWpGaD
Lomitapide—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	6.58e-05	0.00183	CbGpPWpGaD
Lomitapide—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	6.49e-05	0.0018	CbGpPWpGaD
Lomitapide—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	6.04e-05	0.00168	CbGpPWpGaD
Lomitapide—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	5.96e-05	0.00166	CbGpPWpGaD
Lomitapide—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	5.73e-05	0.00159	CbGpPWpGaD
Lomitapide—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	5.65e-05	0.00157	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.95e-05	0.00138	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—GC—chronic obstructive pulmonary disease	4.82e-05	0.00134	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	4.61e-05	0.00128	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.48e-05	0.00125	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	4.01e-05	0.00111	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	3.84e-05	0.00107	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	3.68e-05	0.00102	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	3.6e-05	0.001	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	3.43e-05	0.000955	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.05e-05	0.00085	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	3.03e-05	0.000842	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	2.97e-05	0.000827	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.76e-05	0.000768	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.63e-05	0.000733	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	2.6e-05	0.000724	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	2.38e-05	0.000661	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.31e-05	0.000642	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.19e-05	0.000609	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.83e-05	0.000508	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.8e-05	0.000501	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.68e-05	0.000467	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.62e-05	0.000452	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	1.6e-05	0.000446	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.59e-05	0.000443	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	1.46e-05	0.000407	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.35e-05	0.000375	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.12e-05	0.000313	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.11e-05	0.000309	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	1.08e-05	0.000301	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.03e-05	0.000288	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.03e-05	0.000288	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	9.8e-06	0.000273	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	6.66e-06	0.000185	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	6.37e-06	0.000177	CbGpPWpGaD
